EU antitrust regulators have issued a formal statement of objections to Alchem International on Thursday, accusing the Indian drugmaker of participating in a pharmaceutical cartel to fix prices of a key ingredient used in drugs for stomach complaints. The allegations suggest that Alchem conspired with its rivals to manipulate the market for this essential component, leading to potentially higher costs for consumers. The formal complaint marks a significant step in the EU's ongoing efforts to combat anti-competitive practices in the pharmaceutical industry.
EU antitrust regulators on Thursday accused Indian drugmaker Alchem International of taking part in a pharmaceutical cartel to fix the prices of a key ingredient. https://t.co/RNhaD4f2NW https://t.co/RNhaD4f2NW
Alchem has been hit with a formal antitrust complaint for allegedly plotting with rivals to fix prices of a key ingredient in drugs used for stomach complaints https://t.co/NnOXVFUNqY
Alchem has been hit with a formal antitrust complaint for allegedly plotting with rivals to fix prices of a key ingredient in drugs used for stomach complaints https://t.co/vFNRTV0GWG